Paxlovid: Is Africa Ready For The New Phase Of Covid-19 Treatment?

In November 2021, a mid-to-late stage study showed that an antiviral medication was nearly 90% effective in preventing hospitalisations and deaths in adults at high risk of severe illness. By December, the Paxlovid was cleared for Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) in America and…

You must be registered to view this content.
Register for free | Login

Patsy Nwogu

Reporting on data-driven featured stories and investigations.

Related post